Utilization, cost, and specialty distribution of topical ruxolitinib prescribing in Medicare Part D, 2018-2024: A cross-sectional study. // JAAD International. – URL: https://www.sciencedirect.com/science/article/pii/S2666328726001483?dgcid=rss_sd_all
Utilization, cost, and specialty distribution of topical ruxolitinib prescribing in Medicare Part D, 2018-2024: A cross-sectional study. JAAD International. https://www.sciencedirect.com/science/article/pii/S2666328726001483?dgcid=rss_sd_all
“Utilization, cost, and specialty distribution of topical ruxolitinib prescribing in Medicare Part D, 2018-2024: A cross-sectional study.” JAAD International.
@article{article116962,
title = {Utilization, cost, and specialty distribution of topical ruxolitinib prescribing in Medicare Part D, 2018-2024: A cross-sectional study},
journal = {JAAD International},
url = {https://www.sciencedirect.com/science/article/pii/S2666328726001483?dgcid=rss_sd_all}
}